Advertisement
U.S. Markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6264-0.0116 (-1.82%)
At close: 04:00PM EDT
0.6165 -0.01 (-1.58%)
After hours: 04:06PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Bolt Biotherapeutics Announces Changes to its Board of Directors

    REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Jakob Dupont, M.D., to its Board of Directors. Dr. Dupont brings more than two decades of experience in the field of oncology and immuno-oncology. With the appointment of Dr. Dupont, Executive Partner at Sofinnova Investments, Dr. Jim Healy, M.D., Ph.D., also at Sof

  • GlobeNewswire

    Bolt Biotherapeutics to Participate in Upcoming September Conferences

    REDWOOD CITY, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in September: Morgan Stanley 22nd Annual Global Healthcare ConferenceFireside chat on Friday, Sept. 6, at 7:00 a.m. EDT (4:00 a.m. PDT)H.C. Wainwright 26th Annual Global Investment ConferenceCompany presentation available on